APA
Rath C. M., Benton B. M., de Vicente J., Drumm J. E., Geng M., Li C., Moreau R. J., Shen X., Skepper C. K., Steffek M., Takeoka K., Wang L., Wei J., Xu W., Zhang Q. & Feng B. Y. (20190620). Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted Metabolomics. : ACS infectious diseases.
Chicago
Rath Christopher M, Benton Bret M, de Vicente Javier, Drumm Joseph E, Geng Mei, Li Cindy, Moreau Robert J, Shen Xiaoyu, Skepper Colin K, Steffek Micah, Takeoka Kenneth, Wang Lisha, Wei Jun-Rong, Xu Wenjian, Zhang Qiong and Feng Brian Y. 20190620. Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted Metabolomics. : ACS infectious diseases.
Harvard
Rath C. M., Benton B. M., de Vicente J., Drumm J. E., Geng M., Li C., Moreau R. J., Shen X., Skepper C. K., Steffek M., Takeoka K., Wang L., Wei J., Xu W., Zhang Q. and Feng B. Y. (20190620). Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted Metabolomics. : ACS infectious diseases.
MLA
Rath Christopher M, Benton Bret M, de Vicente Javier, Drumm Joseph E, Geng Mei, Li Cindy, Moreau Robert J, Shen Xiaoyu, Skepper Colin K, Steffek Micah, Takeoka Kenneth, Wang Lisha, Wei Jun-Rong, Xu Wenjian, Zhang Qiong and Feng Brian Y. Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted Metabolomics. : ACS infectious diseases. 20190620.